# FDA Inspection 1166753 - Novant Health New Hanover Regional Medical Center - March 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/novant-health-new-hanover-regional-medical-center/a7915e13-e09f-4f09-9a4b-3d5116c0de48
Source feed: FDA_Inspections

> FDA Inspection 1166753 for Novant Health New Hanover Regional Medical Center on March 22, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166753
- Company Name: Novant Health New Hanover Regional Medical Center
- Inspection Date: 2022-03-22
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1261866 - 2025-02-13](https://www.keypedia.com/records/fda_inspections/novant-health-new-hanover-regional-medical-center/bcdf2f5f-2605-4c7f-8103-80faee5315b3)
- [FDA Inspection 1261866 - 2025-02-13](https://www.keypedia.com/records/fda_inspections/novant-health-new-hanover-regional-medical-center/00aa6455-9f6d-4024-b0f6-7ad976b97afb)
- [FDA Inspection 1166753 - 2022-03-22](https://www.keypedia.com/records/fda_inspections/novant-health-new-hanover-regional-medical-center/a0f2a809-5b89-477c-88da-911b2cee144b)

Company: https://www.keypedia.com/companies/novant-health-new-hanover-regional-medical-center/c958197d-958f-4ad1-88b6-05add010da51

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d